Continuing Aspirin Reduces Thromboembolic Risk in Gastroenterological Surgery

Researchers conducted a multicenter study to assess the impact of continuing preoperative aspirin monotherapy in patients on antiplatelet therapy (APT) during gastroenterological surgery. The study revealed that patients who continued aspirin had significantly lower rates of thromboembolic complications compared to those who discontinued aspirin or were not on APT. These findings emphasize the importance of maintaining preoperative aspirin therapy to reduce the risk of thromboembolic consequences in elective gastroenterological surgery.